ELI LILLY $51.37

down -0.98


19/6/2013 04:19 PM  |  NYSE : LLY  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 51.37
Trade Time: Jun 19 4:08 PM Eastern Daylight Time
Change: -0.98 (-1.87 %)
Prev Close: 52.35
Open: 52.28
Bid: 51.34
Ask: 51.49
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get LLY Trend Analysis - it has outperformed the S&P 500 by 1%

ETF Alternatives



People viewing LLY also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 5.5K +1.50%
WPHM WINSTON PHARMACEUTICALS 20.0K +1.50%
CKGT CHINA KANGTAI CACTUS BIO 500.0 +1.11%
MLGGY MELDEX INTERNATIONAL 300.0 +1.00%
PARS PHARMOS 3.2K +0.73%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
6/17/2013 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $52.45 -6.93%
5/31/2013 Alvarez Ralph Director 156 $52.00 0.90%
5/15/2013 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $56.15 -6.48%
5/10/2013 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health -10,000 $54.49 -16.19%
5/1/2013 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health -4,635 $55.38 -6.98%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LLY), click here.

LLY Stock Analysis

  1. Positive Data on Incyte/LLY's Baricitinib - Analyst Blog

    Incyte and Eli Lilly announced positive results from a study on baricitinib.
  2. Lilly Alzheimer's Study Terminated - Analyst Blog

    The phase II study was voluntarily terminated due to the identification of abnormal liver biochemical tests during routine monitoring.
  3. CHMP Positive on Sanofi's Lantus - Analyst Blog

    The Committee for Medicinal Products for Human Use issued a positive opinion related to Lantus
  4. Investing For The Global Diabetes Epidemic

    Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with the companies that are fighting this epidemic.
  5. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    Teva's partnership with Alexza looks like an expensive gamble.
Free Reports
  1. Five Chart Patterns You Need to Know!

    Time tested chart patterns for maximum profits. Learn more in this free report from ChartAdvisor.com.
  2. View the Portfolios of the Worlds Top Investors, FREE!

    Learn from Warren Buffett, George Soros and More!
  3. 4 Best Buy ETFs for the Current Market

    Don't miss this FREE Special Report from Forbes' fund and ETF expert Jim Lowell.
Marketplace
Trading Center